Principal Investigator

Vincent P
Awardee Organization

Feinstein Institute For Medical Research
United States

Fiscal Year
Activity Code
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Northwell Health NCORP

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2). The global pandemic that started in China in December 2019 has seen both development of vaccines in December 2020, and emergence of successive variants of the virus which alter the efficacy of the available vaccines. At this point in time, the correlates of susceptibility have not been adequately characterized, particularly in patients with compromised immunologic status. Reducing SARS-CoV-2 transmission, morbidity and mortality at both the individual and population level will require better understanding of immunity to this virus. The Serological Sciences Network (SeroNet) was established in 2020 as a consortium of institutions to explore the diagnostic and investigative laboratory science of immunity to SARS-CoV-2, and to prospectively track cohort populations for outcomes, with especial attention to post-vaccination outcomes in susceptible individuals. For this study, 11 of the SeroNet institutions have come together for a "Pooling Project" consisting of conducting real-world data (RWD) analysis using electronic medical record (EMR) data (4 institutions); conducting meta-analyses of the ongoing prospective cohort studies (8 institutions); and investigating heterogeneity in vaccine effectiveness according to age, social determinants of health (SDoH), common clinical risk factors, and laboratory-based correlates of immunohematologic function (4 institutions). This Feinstein (FIMR)/Northwell application is for the purposes of: (a) serving as lead institution for the RWD analyses of patients with autoimmune conditions (systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease); (b) serving as co-lead institution for the RWD analyses of patients with cancer; and (c) serving as co-lead institution for the meta-analysis of prospective cohort studies of patients with systemic lupus erythematosus. Northwell health is a nonprofit integrated healthcare network that is New York State's largest healthcare provider, and by patient volumes over the length of the pandemic, has been one of the top healthcare systems in the country for care of COVID-19 patients. Thanks to its in-system integrated laboratory network (Northwell Health Laboratories), extensive SARS-CoV-2 RWD is available, both for diagnostic (PCR) and serologic (Antibody) testing. This 2-year project will pursue both analysis of extant RWD, and monitoring of the relevant cohort populations over the course of the 2-year study


  • Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J. Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast cancer research and treatment. 2017 Jun;163(2):391-398. Epub 2017 Mar 10. PMID: 28283904
  • Fobare S, Kohlschmidt J, Ozer HG, Mrózek K, Nicolet D, Mims AS, Garzon R, Blachly JS, Orwick S, Carroll AJ, Stone RM, Wang ES, Kolitz JE, Powell BL, Oakes CC, Eisfeld AK, Hertlein E, Byrd JC. Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia. Blood advances. 2022 Mar 8;6(5):1371-1380. PMID: 34847232
  • Skolnick A, Schulman RC, Galindo RJ, Mechanick JI. THE ENDOCRINOPATHIES OF MALE ANOREXIA NERVOSA: CASE SERIES. AACE clinical case reports. 2016 Fall;2(4):e351-e357. PMID: 28868357
  • Budman DR, Calabro A, Rosen L, Lesser M. Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system. Anti-cancer drugs. 2012 Mar;23(3):272-9. PMID: 23427335
  • King DA, Chi J, Goyal SP, Saif MW. COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer. Archives of pharmacology and therapeutics. 2021;3(1):5-9. PMID: 34355214
  • Goyal SP, Vojnic M, Yang JI, Jose J, Newman E, Saif MW. Neoadjuvant Therapy (NAT) in Localized Pancreatic Cancer: Should We Do It and What Should We Do? Journal of cellular signaling. 2021;2(1):80-84. PMID: 34355216
  • Kaplan LD, Maurer MJ, Stock W, Bartlett NL, Fulton N, Pettinger A, Byrd JC, Blum KA, LaCasce AS, Hsi ED, Liu YT, Scott DW, Hurd D, Ruppert AS, Hernandez-Ilizaliturri F, Leonard JP, Cheson BD. Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. American journal of hematology. 2020 Jun;95(6):583-593. Epub 2020 Apr 6. PMID: 32170769
  • Eisfeld AK, Kohlschmidt J, Mrózek K, Blachly JS, Walker CJ, Nicolet D, Orwick S, Maharry SE, Carroll AJ, Stone RM, de la Chapelle A, Wang ES, Kolitz JE, Powell BL, Byrd JC, Bloomfield CD. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. Leukemia. 2018 Jun;32(6):1338-1348. Epub 2018 Feb 25. PMID: 29563537
  • Bhatnagar B, Blachly JS, Kohlschmidt J, Eisfeld AK, Volinia S, Nicolet D, Carroll AJ, Block AW, Kolitz JE, Stone RM, Mrózek K, Byrd JC, Bloomfield CD. Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3). Leukemia. 2016 Jul;30(7):1586-9. Epub 2015 Dec 16. PMID: 26669971
  • Neumann M, Murphy N, Seetharamu N. The Evolving Role of PD-L1 Inhibition in Non-Small Cell Lung Cancer: A Review of Durvalumab and Avelumab. Cancer medicine journal. 2022 Apr;5(1):31-45. Epub 2021 Dec 7. PMID: 35253011
  • Chi J, Chitty D, Lee M, Hakim N, Lakhani S, Rajdev L, Zhu X, Saif MW. COVID-19 Clinical Research. Journal of cellular signaling. 2020 Jun;1(2):23-30. Epub 2020 May 5. PMID: 32607505
  • Walker AR, Marcucci G, Yin J, Blum W, Stock W, Kohlschmidt J, Mrózek K, Carroll AJ, Eisfeld AK, Wang ES, Jacobson S, Kolitz JE, Thakuri M, Sutamtewagul G, Vij R, Stuart RK, Byrd JC, Bloomfield CD, Stone RM, Larson RA. Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance). Blood advances. 2021 Jul 13;5(13):2775-2787. PMID: 34251414
  • Flores S, Kurian N, Yohannan A, Persaud C, Saif MW. Consequences of the COVID-19 Pandemic on Cancer Clinical Trials. Cancer medicine journal. 2021 Apr 1;4(1):38-43. Epub 2020 Jun 3. PMID: 32601623
  • Delahanty LM, Wadden TA, Goodwin PJ, Alfano CM, Thomson CA, Irwin ML, Neuhouser ML, Crane TE, Frank E, Spears PA, Gillis BP, Hershman DL, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hudis C, Winer EP, A Carey L, Partridge AH, Ligibel JA. The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring, Md.). 2022 Jan;30(1):28-38. PMID: 34932888
  • Ehrlich MI, Saif MW. Potential Impact of Delay in Cancer Screening due to COVID-19. Cancer medicine journal. 2021 Aug 1;4(2):44-47. Epub 2020 Jun 3. PMID: 32601624
  • Chi J, Chung SY, Prasad S, Saif MW. The Role of Olaparib in Metastatic Pancreatic Cancer. Cancer medicine journal. 2021 Dec;4(3):89-91. Epub 2021 May 11. PMID: 34151318
  • Aziz H, Hanna K, Saif MW, Rauf MA, Genyk Y, Sheikh MR. Hepatectomy for Breast Cancer Metastasis and Sarcoma are more likely to have Adverse Outcomes than Hepatectomy for Primary Hepatocellular Cancer or for Colorectal Metastasis. Cancer medicine journal. 2020 Nov;3(Suppl 1):6-12. Epub 2020 Jul 23. PMID: 33196059
  • Ghaly M, Gogineni E, Herman J, Saif MW. New Potential Options for SBRT in Pancreatic Cancer. Cancer medicine journal. 2021 Mar;4(Suppl 3):41-50. Epub 2021 Feb 18. PMID: 34355218
  • Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-oncology. 2016 Apr;18(4):565-74. Epub 2015 Oct 22. PMID: 26493095
  • Galindo RJ, Romao I, Valsamis A, Weinerman S, Harris YT. Hypercalcemia of Malignancy and Colorectal Cancer. World journal of oncology. 2016 Feb;7(1):5-12. PMID: 26998187
  • Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia. The New England journal of medicine. 2008 May 1;358(18):1919-28. PMID: 18450603
  • Saif MW. Outstanding Outcome of Pancreatic Cancer: What Lessons Do We Learn. Pancreas (Fairfax, Va.). 2020 Feb;4. Epub 2020 Feb 12. PMID: 32685869
  • Basch E, Dueck AC, Rogak LJ, Minasian LM, Kelly WK, O'Mara AM, Denicoff AM, Seisler D, Atherton PJ, Paskett E, Carey L, Dickler M, Heist RS, Himelstein A, Rugo HS, Sikov WM, Socinski MA, Venook AP, Weckstein DJ, Lake DE, Biggs DD, Freedman RA, Kuzma C, Kirshner JJ, Schrag D. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials. JAMA oncology. 2017 Aug 1;3(8):1043-1050. PMID: 28208174
  • Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). The oncologist. 2019 Jun;24(6):e284-e291. Epub 2019 Apr 11. PMID: 30975921
  • Beumer JH, Owzar K, Lewis LD, Jiang C, Holleran JL, Christner SM, Blum W, Devine S, Kolitz JE, Linker C, Vij R, Alyea EP, Larson RA, Ratain MJ, Egorin MJ. Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer chemotherapy and pharmacology. 2014 Nov;74(5):927-38. Epub 2014 Aug 28. PMID: 25163570
  • Saif MW. New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020. JOP : Journal of the pancreas. 2020 Aug;21(5):108-111. PMID: 32905526
  • Kolitz JE, George SL, Benson DM Jr, Maharry K, Marcucci G, Vij R, Powell BL, Allen SL, Deangelo DJ, Shea TC, Stock W, Bakan CE, Hars V, Hoke E, Bloomfield CD, Caligiuri MA, Larson RA, Alliance for Clinical Trials in Oncology. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. Cancer. 2014 Apr 1;120(7):1010-7. Epub 2013 Dec 31. PMID: 24382782
  • Zent CS, Victoria Wang X, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, Litzow MR, Tallman MS. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). American journal of hematology. 2016 Mar;91(3):308-12. Epub 2016 Feb 9. PMID: 26662208
  • Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. The oncologist. 2019 May;24(5):617-623. Epub 2018 Nov 8. PMID: 30409792
  • Saif MW, Hakim N, Chi J, Rehman H, Goyal SP, Olazagasti C, Sheperd PF, Jose J. First Analysis of Same-day Pegfilgrastim Use with Concurrent Capecitabine-based Regimens in Patients with Gastrointestinal Malignancies. Cancer medicine journal. 2021 Mar;4(Suppl 3):1-6. Epub 2020 Dec 30. PMID: 33655238
  • Budman DR, Tai J, Calabro A, John V. The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines. Investigational new drugs. 2011 Dec;29(6):1224-9. Epub 2010 Jun 9. PMID: 20533074
  • Runcie K, Budman DR, John V, Seetharamu N. Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Molecular medicine (Cambridge, Mass.). 2018 Sep 24;24(1):50. PMID: 30249178
  • Warner-Cohen J, Jose J, Saif MW. Years of Fight against Pancreatic Cancer by RGB: Lessons to be Learnt. Cancer medicine journal. 2020 Dec;3(Suppl 2):7-8. Epub 2020 Nov 19. PMID: 33634269
  • Nano O, Nieto MJ, Saif MW, Tarabichi M. Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 to 2015. Cancer medicine journal. 2020 Dec;3(Suppl 2):30-37. Epub 2020 Dec 7. PMID: 33634270
  • Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AK. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood advances. 2022 Oct 11;6(19):5570-5581. PMID: 35788257
  • Marcucci G, Geyer S, Laumann K, Zhao W, Bucci D, Uy GL, Blum W, Eisfeld AK, Pardee TS, Wang ES, Stock W, Kolitz JE, Kohlschmidt J, Mrózek K, Bloomfield CD, Stone RM, Larson RA. Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. Blood advances. 2020 Feb 25;4(4):696-705. PMID: 32092139
  • Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA. 2017 Jan 3;317(1):48-58. PMID: 28030702
  • Godara A, Kumar A, Miller KB, Saif MW. Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of Literature. Cancer medicine journal. 2021 Aug 1;4(2):52-59. Epub 2020 Jun 11. PMID: 32685937
  • Baig MZ, Filkins A, Khan M, Saif MW, Aziz H. Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer. JOP : Journal of the pancreas. 2021;22(2):36-41. Epub 2021 Mar 30. PMID: 34354555
  • Uy GL, Mandrekar SJ, Laumann K, Marcucci G, Zhao W, Levis MJ, Klepin HD, Baer MR, Powell BL, Westervelt P, DeAngelo DJ, Stock W, Sanford B, Blum WG, Bloomfield CD, Stone RM, Larson RA. A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001. Blood advances. 2017 Jan 24;1(5):331-340. PMID: 29034366
  • Patel SP, Othus M, Chen Y, Wright GP Jr, Yost KJ, Hyngstrom JR, Hu-Lieskovan S, Lao CD, Fecher LA, Truong TG, Eisenstein JL, Chandra S, Sosman JA, Kendra KL, Wu RC, Devoe CE, Deutsch GB, Hegde A, Khalil M, Mangla A, Reese AM, Ross MI, Poklepovic AS, Phan GQ, Onitilo AA, Yasar DG, Powers BC, Doolittle GC, In GK, Kokot N, Gibney GT, Atkins MB, Shaheen M, Warneke JA, Ikeguchi A, Najera JE, Chmielowski B, Crompton JG, Floyd JD, Hsueh E, Margolin KA, Chow WA, Grossmann KF, Dietrich E, Prieto VG, Lowe MC, Buchbinder EI, Kirkwood JM, Korde L, Moon J, Sharon E, Sondak VK, Ribas A. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. The New England journal of medicine. 2023 Mar 2;388(9):813-823. PMID: 36856617
  • Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming GF, Bernhard J. Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British journal of cancer. 2016 Apr 26;114(9):956-64. Epub 2016 Apr 19. PMID: 27092785
  • Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. American journal of hematology. 2016 Feb;91(2):199-204. Epub 2015 Nov 26. PMID: 26526191
  • Mrózek K, Kohlschmidt J, Blachly JS, Nicolet D, Carroll AJ, Archer KJ, Mims AS, Larkin KT, Orwick S, Oakes CC, Kolitz JE, Powell BL, Blum WG, Marcucci G, Baer MR, Uy GL, Stock W, Byrd JC, Eisfeld AK. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia. 2023 Apr;37(4):788-798. Epub 2023 Feb 23. PMID: 36823396
  • Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrózek K, Bloomfield CD, Larson RA. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer. 2013 Jan 1;119(1):90-8. Epub 2012 Jun 28. PMID: 22744771
  • Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK. Sorafenib for Advanced and Refractory Desmoid Tumors. The New England journal of medicine. 2018 Dec 20;379(25):2417-2428. PMID: 30575484
  • Ehrlich MI, Saif MW. Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic? Archives of cancer biology and therapy. 2020;1(1):22-24. PMID: 32728674
  • Nieto MJ, Li Z, Rehman H, Saif MW. Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015. Journal of clinical haematology. 2021;2(1):5-13. PMID: 33834180
  • Saif MW. From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review. JOP : Journal of the pancreas. 2021;22(3):70-79. Epub 2021 May 31. PMID: 34483790
  • Newman J, Seetharamu N, Saif MW. Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors. Cancer medicine journal. 2020 Dec;3(Suppl 2):17-21. Epub 2020 Nov 19. PMID: 33377136
  • Saif MW. Challenges to Treat Cancer Patients During COVID-19 Pandemic. Annals of King Edward Medical University. 2020 Jun 23;26(Suppl 1):100-103. Epub 2020 Jul 9. PMID: 33194225
  • Saif MW, Smith MH, Goodman MD, Salem RR. Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9? JOP : Journal of the pancreas. 2020 Aug;21(5):74-80. Epub 2020 Aug 31. PMID: 32982620